Total planned funding: $177,804,039
Allocations
Countries/Regions
| India | $177,804,039 |
Organizational Types
| Unknown | $89,233,561 |
| NGO | $40,362,560 |
| Own Agency | $27,118,429 |
| University | $8,490,217 |
| Private Contractor | $3,339,272 |
| Implementing Agency | $3,100,000 |
| FBO | $2,500,000 |
| Multi-lateral Agency | $2,460,000 |
| Host Country Government Agency | $1,200,000 |
Program Areas
| Governance and Systems | $68,765,394 |
| Prevention | $45,208,213 |
| Care | $25,119,658 |
| Management and Operations | $21,347,742 |
| Testing | $9,489,206 |
| Treatment | $7,873,826 |
Budget Codes
| OHSS: Health Systems Strengthening | $38,309,756 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $23,491,596 |
| HVSI: Strategic Information | $22,572,653 |
| HVMS: Management and Operations | $21,347,742 |
| HBHC: Care: Adult Care and Support | $15,683,683 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $10,796,360 |
| HVCT: Testing: HIV Testing and Counseling | $9,489,206 |
| HLAB: Laboratory Infrastructure | $7,882,985 |
| HTXS: Treatment: Adult Treatment | $7,134,061 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $4,590,064 |
| HKID: Care: Orphans and Vulnerable Children | $4,480,187 |
| HVTB: Care: TB/HIV | $4,291,009 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $4,200,945 |
| HMBL: Biomedical Prevention: Blood Safety | $2,129,248 |
| PDTX: Treatment: Pediatric Treatment | $716,288 |
| PDCS: Care: Pediatric Care and Support | $664,779 |
| HTXD: Treatment: ARV Drugs | $23,477 |
| HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$89,233,561
Countries/Regions
USG Aggregated Agencies:
$21,125,530
Countries/Regions
FHI 360:
$11,711,825
Countries/Regions
Voluntary Health Services:
$7,960,000
Countries/Regions